Financial News
Albireo Pharma Inc (NQ: ALBO )
35.06
USD
+0.18
(+0.52%)
Official Closing Price
Updated: 4:27 PM EST, Jan 22, 2021
Add to My Watchlist
All news about Albireo Pharma Inc
Albireo to Host Virtual Investor Commercial Day 2021
January 07, 2021
Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 11, 2020
The Week Ahead In Biotech: The Vaccine Updates, Drug Presentations, And FDA Decisions That Will Move The Markets
November 15, 2020
From Benzinga
Albireo Reports Q3 2020 Financial Results and Provides Business Update
November 05, 2020
Albireo Announces Presentations at NASPGHAN 2020 Annual Meeting
October 23, 2020
Cramer Gives His Opinion On Cloudera, Barrick Gold And More
October 20, 2020
From Benzinga
Albireo Recognizes PFIC Awareness Day 2020
October 05, 2020
First Week of November 20th Options Trading For Albireo Pharma
September 24, 2020
Tags
Stocks
From Market News Video
Notable Insider Buys of the Past Week: Nikola, Transdigm And More
September 20, 2020
From Benzinga
Insider Buys Albireo Pharma's Shares
September 15, 2020
From Benzinga
Investors Land ALBO Even Cheaper Than Its Secondary Stock Offering
September 11, 2020
Tags
Stocks
From Market News Video
Albireo Prices Public Offering of 4,000,000 Shares of Common Stock
September 09, 2020
44 Stocks Moving in Wednesday's Pre-Market Session
September 09, 2020
From Benzinga
64 Biggest Movers From Yesterday
September 09, 2020
From Benzinga
Albireo Pharma Joins Elite Club Of Stocks With RS Ratings Over 90
September 09, 2020
Mid-Afternoon Market Update: Dow Falls 1.5%; Nikola Shares Surge
September 08, 2020
From Benzinga
Why Albireo Pharma Stock Is Skyrocketing Today
September 08, 2020
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.